City

Chicago (1)

Cleveland (1)

Houston (1)

Miami (1)

New York (1)

Rochester (1)

San Francisco (1)

Seattle (1)

Washington (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Phase

n/a (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Fred Hutchinson Cancer Center (1)

M.D. Anderson Cancer Center (1)

Northwestern University (1)

Collaborator

National Cancer Institute (NCI) (2)

Millennium Pharmaceuticals, Inc. (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

The Leukemia and Lymphoma Society (1)

Study Documents

Intervention Type

drug (3)

biological (2)

other (2)

procedure (2)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

acute megakaryoblastic leukemia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting

Acute Erythroid Leukemia
+10 more

Fludarabine
+5 more

San Francisco, California
+5 more

Nov 1, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
+14 more

Aldesleukin
+7 more

Houston, Texas

M D Anderson Cancer Center

Jul 31, 2022

Acute Megakaryoblastic Leukemia, Myelofibrosis, Primary Myelofibrosis Trial in Miami, Chicago, Rochester (Alisertib, Laboratory

Active, not recruiting

Has Results

Acute Megakaryoblastic Leukemia
+2 more

Alisertib
+2 more

Miami, Florida
+2 more

May 4, 2021